Year
2025202420232022202120192018201720162015201420132012201120102009200820072006200520042003200220012000
Edition number
№7 / 2020
REVIEWS
E.A. Degtiareva, S.A. Protsenko, E.N. Imyanitov
Rare immuno-mediated adverse events: literature review8-14
T.Yu. Semiglazova (1, 2), V.V. Semiglazov (1, 3), V.V. Klimenko (1), N.A. Brish (1), Yu.V. Alekseeva (1), V.A. Klyuge (1), A.A. Krutov (1), R.M. Paltuev (1), B.S. Kasparov (1), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study15-23
L.E. Gurevich, E.V. Bondarenko, V.E. Ashevskaya, D.N. Fedorov
The role of multidisciplinary centers in the diagnosis and treatment of neuroendocrine tumors: the experience of the Russian Expert Center for the morphological diagnosis of neuroendocrine tumors of the digestive tract at the M.F. Vladimirsky Moscow Regional Research Clinical Institute (MONIKI)24-33
T.Yu. Semiglazova (1, 2), V.A. Zagoruyko (1), A.G. Radzhabova (1), E.V. Tkachenko (1), G.M. Teletaeva (1), D.Kh. Latipova (1), A.I. Semenova (1), V.V. Semiglazov (1, 3), L.V. Filatova (1), S.A. Protsenko (1)
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma34-40
ORIGINAL ARTICLES
N.P. Belyak (1, 2), R.V. Orlova (1, 2), S.I. Kutukova (1, 3), N.V. Zhukova (1, 2), S.A. Borozdina (2)
Evaluation of the effectiveness of adjuvant chemotherapy for locally advanced gastric cancer in real clinical practice41-45
S.S. Ereschenko, V.F. Semiglazov, P.V. Krivorotko, G.A. Dashyan, V.O. Smirnova, A.V. Komyakhov, L.P. Gigolaeva, E.K. Zhiltsova
Treatment of residual breast cancer46-52
L.Yu. Vladimirova, N.A. Abramova, I.L. Popova, K.A. Novoselova, N.M. Tikhanovskaya, L.A. Ryadinskaya, A.A. Lyanova, V.S. Myagkova, M.A. Teplyakova, A.E. Storozhakova, E.A. Kalabanova, N.Yu. Samaneva, S.N. Kabanov, Y.V. Svetitskaya, A.V. Tishina, L.K. Strakhova, M.O. Yezhova
The combination of gemcitabine and nab-paclitaxel in patients with locally advanced and advanced pancreatic cancer53-57
A.P. Oganesyan (1), S.A. Protsenko (1), I.A. Baldueva (1), A.V. Novik (1, 2), D.Kh. Latipova (1), A.I. Semenova (1), G.M. Teletaeva (1)
Comparison of systems for evaluating the effectiveness of modern immunotherapy58-61
S.I. Kutukova (1, 2), A.B. Chukhlovin (1), A.I. Yaremenko (1), N.P. Belyak (1, 3), Yu.V. Ivaskova (1, 2), A.Ya. Razumova (1), T.S. Ermakova (2)
Survival analysis of patients with oral squamous cell carcinoma in association with DNA of the main types of oncogenic oral viruses62-67
M.S. Knyazeva, V.A. Zagoruyko, E.V. Borisov, E.I. Sidina, N.S. Nikiforova, M.A. Slyusarenko, I.V. Nazarova, A.I. Semenova, A.K. Nosov, S.A. Protsenko, A.V. Malek
Evaluation of the effectiveness and the possibility of optimizing the methodology for analyzing the plasma microRNA-371-3 (HSA-miR-371-3p) level for the diagnosis and monitoring of the effect of therapy of germ cell tumors in men68-75
K.O. Kondratyeva, T.Yu. Semiglazova, B.S. Kasparov, M.V. Vagaitseva, V.A. Klyuge
Antivital experiences of oncologic patients against the background of antitumor treatment and in the long term period76-80
V.A. Chubenko
Metronome therapy: a new rhythm – new opportunities81-84
L.V. Filatova (1, 2)
Immunotherapy of diffuse large B-cell lymphoma85-95
T.Yu. Semiglazova (1, 2), O.A. Volynshchikova (1), V.V. Semiglazov (1, 3), V.V. Klimenko (1), N.A. Brish (1), Yu.V. Alekseeva (1), V.A. Klyuge (1), A.A. Krutov (1), R.M. Paltuev (1), B.S. Kasparov (1), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
Abemacyclib – new options for the treatment of hormone- positive metastatic breast cancer with CDK4/6 inhibitors96-103
D.O. Yurlov, S.A. Protsenko, I.A. Baldueva
Predictive and prognostic markers in the treatment of patients with solid tumors104-110
V.I. Gorbachev (1), M.V. Burikov (2), R.A. Lepetyukhin (2), D.V. Morozov (3), S.M. Gorbacheva (1), E.S. Netesin (1)
Legal and clinical aspects of opioid analgesics111-115
S.A. Protsenko (1), E.M. Anokhina (2), R.V. Orlova (3, 4)
The experience of using the combined targeted regimen vemurafenib+cobimetinib in the treatment of metastatic skin melanoma with a BRAF V600E mutation in a patient with HIV infection receiving antiretroviral therapy116-123
G.A. Khakimov (1, 2), Zh.B. Sadullaev (1, 2), G.G. Khakimova (3)
Difficulties in diagnosing primary pulmonary Hodgkin’s lymphoma. Case report124-127
